Circulating miR-122 Is a Predictor for Virological Response in CHB Patients With High Viral Load Treated With Nucleos(t)ide Analogs

Circulating miR-122 Is a Predictor for Virological Response in CHB Patients With High Viral Load Treated With Nucleos(t)ide Analogs

Chronic hepatitis B (CHB) infection remains worldwide health problem. Antiviral treatment options for CHB patients include nucleos(t)ide analogs (NAs) and interferon. Most of the current biomarkers for predicting treatment response are virus-dependent. MicroRNA-122 is the most abundant liver-specifi...

Full description

Bibliographic Details
Main Authors: Yin Wu, Chang Gao, Shaohang Cai, Muye Xia, Guichan Liao, Xiaoyong Zhang, Jie Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Genetics
Subjects:
microRNA-122
chronic hepatitis B
virological response
high viral load
nucleos(t)ide analogs
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2019.00243/full

Internet

https://www.frontiersin.org/article/10.3389/fgene.2019.00243/full

Similar Items